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Abstract
A longer lifetime duration of breastfeeding may decrease the risk of breast cancer by reducing breast inflammation
and mitigating inflammatory cytokine expression during postlactational involution. However, little is known about
how the inflammatory cytokine profile in human breastmilk changes over time. To study temporal trends in
breastmilk cytokine expression, we measured 80 human cytokines in the whey fraction of breastmilk samples
from 15 mothers at 1, 4, 8, and 12 weeks postpartum. We used mixed models to identify temporal changes in
cytokine expression and investigated parity status (multiparous vs. primiparous) as a potential confounder. Nine
cytokines (monocyte chemoattractant protein-1, epithelial-derived neutrophil-activating protein-78, hepatocyte
growth factor, insulin-like growth factor-binding protein-1, interleukin-16, interleukin-8, macrophage colony-
stimulating factor, osteoprotegerin, and tissue inhibitor of metallopeptidase-2) had significantly decreased ex-
pression with increasing breastfeeding duration; all nine have known roles in breast involution, inflammation, and
cancer and may serve as biomarkers of changing breast microenvironment. No cytokine significantly increased in
level over the study period. Total protein concentration significantly decreased over time ( p < 0.0001), which may
mediate the association between length of breastfeeding and inflammatory cytokine expression. Parity status did
not confound temporal trends, but levels of several cytokines were significantly higher among multiparous versus
primiparous women. Our results suggest that inflammatory cytokine expression during lactation is dynamic, and
expressed milk may provide a noninvasive window into the extensive biological changes that occur in the
postpartum breast.
Introduction
Longer lifetime duration of breastfeeding is associ-ated with reduced risk of breast cancer later in life,1–4
although little is known about the underlying mechanisms.
One possible mechanism may relate to glandular involution.
Postlactational breast involution involves extensive breast
tissue remodeling and depends on infiltration of inflamma-
tory cells. This inflammatory microenvironment may tran-
siently increase risk of pregnancy-associated breast cancer,1,5,6
but longer breastfeeding duration may reduce breast inflam-
mation and mitigate tissue remodeling,1,7 thereby improving
postlactational involution outcomes and decreasing breast
cancer risk. However, biomarkers for monitoring breast in-
flammation during lactation and/or predicting risk have re-
ceived only limited study.
Animal studies feature prominently in our understanding
of postlactational involution. These studies have identified
inflammatory cytokines that are differentially expressed
during mammary involution and in cancer development.8–11
Although some research has investigated the expression of
cytokines and other proteins in human breastmilk,12–23 meth-
ods have been diverse, and there is little consensus regarding
the cytokine profile of human milk and how it changes over
time. In fact, most studies of breastmilk cytokines have fo-
cused on exploring cytokines that impact infant nutrition and
health,12–16 identifying known cancer-associated cytokines
in milk,17–19 or investigating cytokines in conjunction with
breast inflammatory diseases and noncancerous maternal con-
ditions.20,21 Few studies have attempted to simultaneously
characterize the coordinated expression of multiple cytokines
in milk,22,23 and longitudinal analyses examining cytokine
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expression throughout lactation and involution are rare and
have had inconsistent results.12,17,18
The present study investigated temporal trends in the ex-
pression of 80 cytokines in the breastmilk of healthy women
throughout the first 3 months of lactation. Information on
total milk protein concentration was also collected. Our two
hypotheses were as follows: (1) global cytokine expression
would decrease over the study period, reflecting altered
breast microenvironment as breastfeeding progresses, and (2)
specific cytokines would be identified as potential biomarkers
of the breast microenvironment throughout lactation.
Materials and Methods
Study population
The Mother’s Milk Microbiome (3M) study included 15
breastfeeding mothers recruited during their hospitalization
in the postpartum unit of a tertiary-care hospital in North
Carolina from July through December 2010. Included were
English-speaking women with a singleton birth at ‡ 37 weeks
of gestation who intended to breastfeed for at least 3 months
and were not experiencing more than mild pain with breast-
feeding. Participants were excluded if they lived more than
30 minutes from the recruitment hospital or if their infant had
a congenital anomaly that interfered with breastfeeding.
Data collection and follow-up
After providing written informed consent, participants
were visited four times in their homes by an International
Board Certified Lactation Consultant. At 1 week postpartum,
participants provided a breastmilk sample (approximately 2–
5 mL from each breast) and completed baseline question-
naires assessing age (continuous), race/ethnicity (white and
other), marital status (single, living as married, and married),
education level (high school, some college, completed col-
lege, and some graduate), body mass index (continuous,
based on self-reported prepregnancy weight), and previous
breastfeeding history (combined months of previous breast-
feeding). Study participants completed three follow-up visits
over the course of 3 months (at 4, 8, and 12 weeks postpar-
tum), at which additional milk samples were collected and
participants reported their daily breastfeeding frequency and
time since last milk expression. Study incentives included
four home visits with breastfeeding support and counseling
by the study’s International Board Certified Lactation Con-
sultant and a gift card ($5–10) for each milk sample donation.
The study protocol was approved by the institutional review
board of the University of North Carolina at Chapel Hill.
Milk sample characteristics and processing
All breastmilk samples were collected manually using
aseptic technique after nipples were cleaned with 70% iso-
propyl alcohol. Milk was collected in sterile plastic con-
tainers, transported on ice to the laboratory, and stored at
- 80C until analysis.
Equal parts of the milk from left and right breasts were
pooled and processed as a single sample for a total of 56
pooled samples for the 15 participants across the four time
points (Supplementary Table S1; Supplementary Data are
available online at www.liebertpub.com/bfm). The whey
fraction of the milk was obtained as previously described by
Kverka et al.22 In brief, 1–1.5 mL of milk was subjected to
two successive centrifugations at 680 g for 10 minutes at 4C
and at 10,000 g for 30 minutes at 4C, after which the fatty
layer and cellular elements were removed. The resulting
translucent liquid whey was used for cytokine array analysis.
To address the question of cytokine degradation during
storage and after freeze–thaw cycles, we measured cytokine
expression within one sample that was subjected to different
freeze–thaw cycles: (1) fresh milk kept on ice (never frozen),
(2) one freeze–thaw cycle (thawed on ice), and (3) two
freeze–thaw cycles (thawed on ice). Milk samples were
randomized and processed after all samples were received to
avoid batch effects.
Cytokine measurement
The RayBio Human Cytokine Antibody Array 5 (80)
(RayBiotech, Norcross, GA) was used to measure the ex-
pression of 80 cytokines in the whey fraction of the milk
samples. We processed the cytokine array glass slides ac-
cording to the manufacturer’s recommendation. In brief, the
slides were blocked with blocking buffer at room temperature
for 30 minutes and incubated with 100 lL of the whey sample
at room temperature for 90 minutes. Slides were washed three
times with Wash Buffer I and two times with Wash Buffer
II at room temperature for 5 minutes per wash and incu-
bated with biotin-conjugated antibodies overnight at 4C.
The slides were washed and incubated with fluorescent dye-
conjugated streptavidin at room temperature for 2 hours. The
slides were then washed again with Buffers I and II and dried
by centrifugation at 200 g for 3 minutes. Immediately after
centrifugation, fluorescent signal was detected on a Gene-
Pix 4000B scanner (Molecular Devices, Sunnyvale, CA)
using a cy3 (green) channel (excitation frequency of 532 nm).
Each slide was normalized to positive controls on individual
slides to obtain relative cytokine expression for comparison
across slides.
Total protein quantification
Using the Pierce BCA Protein Assay Kit (Thermo Scien-
tific, Rockford, IL), total protein concentration was measured
in 45 samples with sufficient remaining whey fraction vol-
ume (Supplementary Table S1). In brief, whey samples were
diluted 1:10 in phosphate-buffered saline, and 10 lL of di-
luted sample was incubated with 200 lL of Kit Reagent in 96-
well plates for 30 minutes at 37C. Samples were assayed in
triplicate, and total protein concentration was measured using
a BioTek (Winooski, VT) EL800 plate reader (excitation
frequency of 570 nm).
Statistical analysis
Prior to analysis, all cytokine expression and protein data
were logarithm-transformed using base 2. Mixed models
were used in a repeated-measures analysis to model changes
in cytokine expression and total protein concentration over
time. Specifically, PROC MIXED (SAS version 9) was used
to model cytokine expression or protein concentration, with
week as the fixed factor and subject as the repeated factor
using an unstructured covariance matrix. Parity status was
dichotomized into multiparous (one or more births prior to
the current birth) versus primiparous (no prior births) and
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evaluated as a potential confounder in multivariable models.
Other covariates (age, race/ethnicity, marital status, educa-
tion, body mass index, and previous breastfeeding history)
were collected, but sample size was insufficient to investigate
these covariates as confounders. Therefore only parity was
included in final models. We also examined daily breast-
feeding frequency and time since last milk expression in
association with cytokine expression. Statistical significance
was defined as p < 0.05, although q values were also esti-
mated using an optimized false discovery rate (FDR) ap-
proach in all cytokine analyses to adjust p values for multiple
testing. Statistical analyses were performed using SAS soft-
ware, version 9.3 (SAS Institute, Inc., Cary, NC).
Data were analyzed using a two-dimensional cluster gen-
erated by Cluster 3.0 and visualized using Java Treeview.
Samples were organized by time point (Week 1, 4, 8, and 12),
and cytokine values were clustered across all samples.
Results
The 15 women in this study were primarily white, married,
and highlyeducatedwithanaverage age of33.9 years (Table1).
Additionally, the women had a low body mass index (average
of 21.7 kg/m2), and all multiparous women had previously
breastfed, with an average lifetime duration of 19.1 months.
Breastmilk samples were collected at 1, 4, 8, and 12 weeks
postpartum for nearly all women (Supplementary Table S1),
and we conducted a series of quality tests to address the
question of sample degradation as a result of storage and
freeze–thaw cycles. We found that Pearson correlations for
overall cytokine expression across the different storage and
freeze–thaw conditions ranged from 0.97 to 0.99 (Supple-
mentary Table S2), suggesting that freezing the samples did
not substantially affect the results of the cytokine assay.
However, two cytokines (epidermal growth factor and GRO)
were found to have poor reproducibility (expression values
were greater than 0.2 SD from the mean across all freeze–
thaw conditions) and were removed from further analysis.
Average cytokine expression and total protein
decrease over the first 8 weeks of lactation
Average cytokine expression decreased over the study
period until Week 8, after which expression increased at
Week 12 (Fig. 1). Similarly, we found that total protein
concentration followed a more pronounced decreasing trend
until Week 8 when the trend plateaued (Fig. 1). The trend
lines for both cytokine expression and total protein decreased
linearly with an inflection point at Week 8, suggesting that
model fit could be improved by fitting a linear spline term at
Week 8.
Three models were considered to evaluate how the inclu-
sion of the spline term and parity status as a potential con-
founder affected the associations between time and average
cytokine expression or total protein. As shown in Table 2, we
did not find a significant association between time and av-
erage cytokine expression in the crude model, although the
model coefficient was negative, suggesting decreased cyto-
kine expression over time. The magnitude of the association
nearly doubled with the inclusion of the spline term, although
the association remained nonsignificant. Similarly, for total
protein concentration (Table 2), the crude model showed that
total protein significantly decreased over time ( p < 0.0001).
Adjusting for parity status had no effect on the association
between time and total protein or between time and cytokine
expression, and thus there was no substantial confounding by
parity. The addition of the spline term strengthened the as-
sociation between time and total protein. Goodness of model
fit was assessed by comparing the Akaike information cri-
terion between the crude and spline models, and the Akaike
information criterion values were either unchanged (for cy-
tokine models) or improved (for total protein models) with a
spline term. Given the shape of the curves in Figure 1, im-
proved flexibility of the spline model, and impact on model
fit, the spline term was retained in cytokine and protein
models.
Average cytokine expression is not associated
with breastfeeding frequency or time
since last milk expression
Daily breastfeeding frequency and time since last milk
expression were considered as factors influencing cytokine
expression over time. Average daily breastfeeding frequency
decreased slightly over the study period (participants aver-
aged 9.8, 9.4, 8.4, and 7.6 daily feedings at Week 1, 4, 8, and
12 postpartum, respectively); however, breastfeeding fre-
quency was not associated with cytokine expression
( p = 0.8). Time since last milk expression varied widely
across the 15 participants and four time points, ranging from
Table 1. Demographic Characteristics of Study
Participants (n = 15)
Characteristic Number (%)
Age (years)
< 35 9 (64.3)







Living as married 2 (13.3)
Education level
Some college 1 (6.7)
Completed college 8 (53.3)
Some graduate 6 (40.0)
BMI (prepregnancy weight) (kg/m2)
< 25 14 (93.3)
‡ 25 1 (6.7)
Number of births (including current)
1 6 (40.0)










aMean – standard deviation.
BMI, body mass index; NA, not applicable.
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5 to 332 minutes (data not shown). Similar to the trend for
average cytokine expression (Fig. 1), average time since last
milk expression decreased from 119.4 minutes at Week 1 to
91.3 minutes at Week 8, after which time since last expres-
sion increased to 100.5 minutes (Supplementary Fig. S1).
However, despite the trend similarities, average time since
last milk expression was not significantly associated with
cytokine expression ( p = 0.2).
Individual cytokines show decreased
expression over time
The temporal change in the expression of each measured
cytokine individually was modeled using mixed models with
a spline term. FDR q values of < 0.05 were considered to
be statistically significant, although unadjusted p values of
< 0.05 were also noted. Of the 78 cytokines that were
measured, the expression of five cytokines (monocyte che-
moattractant protein [MCP]-1, osteoprotegerin, tissue in-
hibitor of metallopeptidase-2 [TIMP-2], insulin-like growth
factor-binding protein-1 [IGFBP-1], and epithelial-derived
neutrophil-activating protein-78 [ENA-78]) were found
to significantly change over the 12-week study period
(q < 0.05), and four other cytokines (hepatocyte growth
factor [HGF], interleukin [IL]-16, IL-8, and macrophage
colony-stimulating factor [M-CSF]) had significant changes
in expression at a = 0.05 (Table 3). Expression values of all
significant cytokines decreased over time; no cytokines
were found to have significantly (q < 0.05 or p < 0.05) in-
creased expression over the study period. As shown in Table
3, the magnitude of the temporal trend was stronger for
individual cytokines than for average cytokine level.
Expression values of all significant cytokines were plotted
over time, and two groups of cytokines were identified based
on the divergence of trend lines at Week 8 (Fig. 2A). After
Week 8, several cytokines (most notably osteoprotegerin,
MCP-1, ENA-78, and IGFBP-1), showed increasing ex-
pression, whereas HGF, IL-16, IL-8, and M-CSF expression
continued to decrease.
Two-dimensional clustering was used to generate a heat
map of the expression data for these nine cytokines (Fig. 2B).
The samples clustered as expected based on Figure 1, with
Week 1 samples clustering together and showing higher cy-
tokine expression and Week 8 samples clustering together
with lower expression. It is interesting that samples from
Week 12 generally clustered with samples from Weeks 1 and
4, mirroring the trend in Figure 1 and suggesting that cytokine
expression may increase at 12 weeks to levels comparable to
the first month postpartum.
Total protein is significantly associated
with cytokine expression
We also examined the association between cytokine ex-
pression and total protein concentration to consider whether
our statistical models should adjust for total protein. Cyto-
kines constitute one class of proteins expressed in breastmilk,
and Qin et al.17 previously suggested that cytokine analyses
in breastmilk should account for total milk protein through
FIG. 1. Average cytokine expres-
sion and total protein concentration
over the first 12 weeks of lactation
(n = 15 participants). Seventy-eight
cytokines were averaged per par-
ticipant. Error bars show the 95%
confidence interval of the mean.
Table 2. Comparing Models: Change in Average
Cytokine Expression and Total Protein over Time
Model, factor b coefficient 95% CI p value
Cytokine expression
Weeka - 0.016 - 0.046, 0.014 0.3
Week + spline - 0.034 - 0.082, 0.013 0.2
Week + parity - 0.016 - 0.046, 0.014 0.3
Total protein
Weeka - 0.045 - 0.060, - 0.029 < 0.0001
Week + spline - 0.068 - 0.089, - 0.048 < 0.0001
Week + parity - 0.045 - 0.061, - 0.030 < 0.0001
aCrude model, with only a continuous variable representing week
of sample collection. Cytokine expression was averaged within each
sample. The spline term added an inflection point at Week 8. Parity
status was defined as multiparous versus primiparous.
CI, confidence interval.
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statistical adjustment or normalization of expression values
to protein concentration. We identified eight cytokines
(ENA-78, granulocyte–macrophage colony-stimulating fac-
tor, IGFBP-1, IL-16, IL-8, MCP-1, MCP-4, and TIMP-2) that
were significantly associated with total protein (Supple-
mentary Table S3), although no q values were significant.
These results suggest that some cytokine expression is as-
sociated with total protein concentration, as expected given
that milk protein levels include the cytokines we measured.
However, we chose not to adjust for total protein in this
analysis for two reasons.
First, trends in Figure 1 suggest that cytokine expression
changes independently of total protein concentration over the
first 12 weeks of lactation. Total protein content declined
sharply over time and eventually stabilized after Week 8,
whereas cytokine expression initially declined but increased
after Week 8. Cytokine expression and total protein do not
appear to change in parallel, and normalizing cytokine ex-
pression values to total protein concentration obscures the
interpretation of changes in cytokine levels over time. Sec-
ond, we considered the biological relationships among cy-
tokine expression, total protein concentration, and duration of
lactation (time). Total protein concentration and cytokine
expression in breastmilk appear to be independently affected
by time, and given that total protein and cytokine expression
are correlated, total protein may be an intermediate in the
association between time and cytokine expression. Thus,
adjusting for total protein would attenuate or obscure the
estimated trends in cytokine expression. However, the cyto-
kine expression and total protein data for all participants are
provided in Supplementary Table S4.
Multiparous women have higher cytokine expression
than primiparous women
Parity status was not identified as a confounder in this
analysis; however, we investigated whether cytokines were
differentially expressed with respect to parity status. We
identified 13 cytokines that were significantly increased
among multiparous women ( p < 0.05), all of which also had
q values < 0.05 (Table 3). Although temporal trends seem
unaffected by parity status, multiparous women appeared to
have higher cytokine expression at baseline and persistently
at subsequent time points.
Discussion
Our results suggest that average global cytokine expres-
sion and total protein concentration decrease over the first 3
months of lactation, with total protein showing a highly
significant decreasing trend. We expected to see a similar
downward trend for both cytokine expression and total pro-
tein content; however, average cytokine expression appeared
to increase after Week 8 of lactation.
Table 3. Individual Cytokines Showing a Significant Decrease over Time
or a Significant Association with Parity Status
Trend, cytokine b coefficient 95% CI p value q value
Decreased over time
ENA-78a - 0.157 - 0.260, - 0.053 0.004 0.04
HGF - 0.083 - 0.151, - 0.014 0.02 0.2
IGFBP-1a - 0.110 - 0.176, - 0.043 0.002 0.03
IL-16 - 0.080 - 0.149, - 0.010 0.03 0.2
IL-8 - 0.103 - 0.185, - 0.020 0.02 0.1
MCP-1a - 0.184 - 0.263, - 0.105 < 0.0001 0.006
M-CSF - 0.070 - 0.139, - 0.002 0.05 0.3
Osteoprotegerina - 0.149 - 0.233, - 0.064 0.001 0.03
TIMP-2a - 0.132 - 0.210, - 0.054 0.002 0.03
Associated with parityb
Eotaxin 0.398 0.004, 0.791 0.05 0.02
Eotaxin-2 0.307 0.003, 0.610 0.05 0.02
Eotaxin-3 0.398 0.045, 0.750 0.03 0.02
GRO-alpha 0.447 0.148, 0.746 0.007 0.01
IGFBP-3 0.467 0.076, 0.858 0.02 0.02
IGFBP-4 0.303 0.008, 0.598 0.05 0.02
IL-15 0.378 0.004, 0.752 0.05 0.02
IL-7 0.428 0.018, 0.837 0.04 0.02
IP-10 0.433 0.018, 0.848 0.04 0.02
TGF-beta1 0.375 0.010, 0.741 0.05 0.02
TIMP-1 0.352 0.128, 0.577 0.005 0.01
Thrombopoetin 0.461 0.054, 0.869 0.03 0.02
VEGF 0.279 0.096, 0.462 0.006 0.01
aSignificant false discovery rate q values (q < 0.05); all other p values were significant at p = 0.05. Models included a linear spline term at Week 8.
bAll presented correlations were significant at p = 0.05 and q = 0.05. Parity status was defined as multiparous (one or more births prior to
the current birth) versus primiparous (no prior births).
CI, confidence interval; ENA-78, epithelial-derived neutrophil-activating protein-78; HGF, hepatocyte growth factor; IGFBP, insulin-like
growth factor-binding protein; IL, interleukin; IP, interferon gamma-induced protein; MCP-1, monocyte chemoattractant protein-1; M-CSF,
macrophage colony-stimulating factor; TIMP-2, tissue inhibitor of metallopeptidase-2; TGF, transforming growth factor; VEGF, vascular
endothelial growth factor.
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Our findings confirm and extend earlier work on temporal
trends in inflammatory cytokine expression in human milk.
Ustundag et al.12 found a similar but significant decrease in
cytokine expression in breastmilk samples from 3 weeks and
2 months postpartum compared with colostrum samples from
Week 1. Their study did not extend beyond 2 months and thus
was not informative regarding trends later in lactation. Qin
et al.17 also reported strongly decreased total milk protein
concentrations at 2 months compared with baseline (within
10 days postpartum) and observed a nonsignificant increase
in total protein content at the time of weaning (an average of
40 weeks postpartum). Similarly, Bauer and Gerss24 ob-
served a significant decline in total protein levels over the first
2 months postpartum in the milk from mothers of term and
preterm infants. Our temporal results are consistent with
these studies despite differences in sampling time frame,
suggesting that cytokine expression and total milk protein
content initially decline until 2 months postpartum, after
which expression may increase.
Further study is needed to clarify and replicate temporal
patterns and link these trends to the onset of weaning. Given
that weaning triggers breast involution, one could hypothe-
size that cytokine expression would increase or level off at
weaning. Future longitudinal studies would benefit from
regular breastmilk sampling from 3 months postpartum to
weaning to better characterize cytokine expression dynamics.
Shifts in lactation biology and breastfeeding behavior
over the first 3 months of lactation may influence temporal
trends in cytokine expression and total protein concentration.
Breastmilk production is thought to switch from endocrine to
autocrine control early in lactation,25 after which milk pro-
duction is regulated locally by the completeness and fre-
quency of breast emptying during feeding.26–28 Given the
known roles of cytokines in cell signaling and secretion, it is
possible that cytokine profiles would be impacted by the
frequency and recentness of milk production. We did not find
that breastfeeding frequency or time since last feeding was
significantly associated with cytokine expression and were
FIG. 2. Expression of significant cytokines over time, averaged across all participants (n = 15). (A) Temporal trends of
significant cytokines over the study period. All expression values were normalized to positive controls and averaged across
all participants. For measures of variability in these temporal cytokine expression trends, see the 95% confidence intervals
presented in Table 3 (cytokines decreased with time). (B) Heat map depicting a two-dimensional, supervised cluster of
cytokine expression data. Only significant cytokines from Table 3 (cytokines decreased with time) were clustered. Red
represents cytokines with high expression, whereas green represents cytokines with low expression relative to the median.
ENA-78, epithelial-derived neutrophil-activating protein-78; HGF, hepatocyte growth factor; IGFBP-1, insulin-like growth
factor-binding protein-1; IL, interleukin; MCP-1, monocyte chemoattractant protein-1; MCSF, macrophage colony-
stimulating factor; TIMP-2, tissue inhibitor of metallopeptidase-2.
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unable to address other breastfeeding behaviors in our study;
however, we found substantial variation across participants
in reported time since last feeding, and it is possible that a
larger sample could better characterize how breastfeeding
recentness might impact cytokine expression.
We identified nine cytokines (ENA-78, HGF, IGFBP-1,
IL-16, IL-8, MCP-1, M-CSF, osteoprotegerin, and TIMP-2)
with significantly varied expression over the study period
( p < 0.05), and five cytokines (ENA-78, IGFBP-1, MCP-1,
osteoprotegerin, and TIMP-2) remained significant after
considering FDR q values (q < 0.05).
All nine significant cytokines previously have been studied
in association with breast cancer, inflammation, or involu-
tion: IL-8 and IL-16 expression is associated with several
cancers, particularly metastatic breast cancer,29,30 and os-
teoprotegerin overexpression has been identified as a prom-
ising prognostic marker of bone metastasis risk.31,32 IL-8
expression in human milk has been suggested to decrease as
breastfeeding progresses, although no previous study had
found a significant trend.12,33,34 Regarding involution, HGF
signaling is involved in wound healing, and ENA-78 ex-
pression is associated with angiogenesis; both cytokines are
key players in tissue remodeling during postlactational in-
volution.5,35 MCP-1 is also a known regulator of angiogen-
esis in addition to promoting macrophage migration and
infiltration, and high MCP-1 expression may reflect higher
levels of overall breast inflammation.36 M-CSF appears to be
essential to successful involution in mice, as mouse knock-
outs show significantly delayed involution.37 Finally, ex-
pression of IGFBP-1 and TIMP-2 has been measured in
human breastmilk, and both cytokines have previously been
found to decrease in level during lactation,38,39 with the
IGFBP-1 level decreasing over the first 3 months postpartum
before stabilizing through Month 9 of lactation.38 It is not yet
known how expression of these cytokines may be interrelated
during lactation, although their known associations with
breast involution, inflammation, and breast cancer suggest
that these nine cytokines may be strong candidates for breast
microenvironment biomarkers. Future experimental work is
needed to establish the biological significance of these cy-
tokines at the concentrations found in human breastmilk.
Postlactational biology may vary in primiparous versus
parous women, but parity status was not a confounder in our
analyses of temporal trends. However, multiparous women
more highly expressed 13 cytokines across the time frame
studied. To our knowledge, no studies have previously
quantified breastmilk cytokine expression by parity status.
This difference in cytokine levels with parity is particularly
interesting in light of findings that risk of basal-like breast
cancer increases with multiparity.2 The regulatory roles of
parity-associated cytokines in breastfeeding, postlactational
involution, and breast cancer merit further study.
Our findings should be considered in light of some limi-
tations and strengths. Because of our small sample size, we
lacked sufficient power to examine potential confounders
other than parity. However, we did pursue careful aseptic
sample collection at multiple time points, ensuring that our
observed time course is free from collection-related micro-
bial contaminants. We identified nine cytokines with poten-
tial to serve as biomarkers of the breast microenvironment;
however, future mechanistic studies are necessary to clarify
the biological significance of these cytokines in the breast
microenvironment throughout lactation. Given that breast-
milk is produced to provide nutrition to the infant, the cyto-
kines we examined may have primary roles in infant
development12,14,16,22 with secondary functions in the breast
microenvironment. Additionally, we noted a shift in the cy-
tokine expression trend after Week 8 postpartum, but our
study period only extended to Week 12. Future studies col-
lecting additional time points over the first year of breast-
feeding are warranted to better understand the trends in
cytokine expression associated with longer breastfeeding.
Conclusions
Our study characterizes cytokine expression in the breast-
milk of healthy women with repeated sampling during the first
3 months of lactation. We present nine cytokines with potential
as biomarkers of the breast microenvironment during breast-
feeding and involution, providing a key first step in identifying
potential cytokine-related biological mechanisms for how
breastfeeding duration may impact future breast cancer risk.
Our results suggest that cytokine expression during lactation is
dynamic, and expressed milk may provide a noninvasive
window into the extensive biological changes that occur in the
postpartum breast. Beyond identifying potential biomarkers to
understand how breastfeeding alters breast tissue, studies such
as ours can also help to inform ideal cutpoints for breastfeeding
exposure in epidemiologic studies. Prior studies have had
conflicting definitions of breastfeeding exposure, partly be-
cause of lack of guidance from biological evidence. Continued
study of breastmilk biomarkers has important implications for
studying breastfeeding in cancer prevention.
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